Amare mental wellness business incentive trip to Riviera Maya

Help those with metabolic health issues and build a business on the side in the area of mental health with Amare. Join here

Text Connie 408-854-1883 to start with a stronger wellness business.

wellness-mental-health-gut

Call about the trip incentive with Amare , 408-854-1883 , as business owner in this wellness business (in the USA and Mexico, Canada and Europe next, now in its 2nd year).

Colon and rectal cancer incidence is rising among Gen X and millennials

Earlier this year, researcher Rebecca Siegel of the American Cancer Society published a startling report showing that colon and rectal cancer incidence is rising among Gen X and millennials while falling in older generations.

On Tuesday, after delving further into the data, she and her co-authors identified “a true and perplexing escalation in disease occurrence.” In a paper in JAMA, the Journal of the American Medical Association, they report that deaths from colorectal cancer are increasing for young and middle-aged Americans — though the increase appears, at least so far, to be confined to white men and women.

The U.S. mortality rate for colorectal cancer for ages 20 to 54 fell from 6.3 per 100,000 in 1970 to 3.9 in 2004. It then began to go up by 1 percent annually. By 2014, the rate was 4.3 per 100,000.

Breaking the numbers out by race reveals the  trend, with the outlook becoming better for blacks and people of other races but not for whites.

The mortality rate for whites had been declining for decades, but it began to climb starting in 2004, going from 3.6 per 100,000 to 4.1 per 100,000 in 2014. For blacks, it went down to 6.1 per 100,000 in 2014. While that’s still higher than for whites, the trend is heading in the right direction. For other races, mortality rates declined until 2006 and remained stable through 2014.

Siegel noted that the racial patterns are “inconsistent” with trends in major risk factors for colorectal cancer. These include obesity, which is increasing among all races and would suggest colorectal cancer rates should be going up among all races, too.

 


The mortality rate for white Americans declined for a number of years but began to rise again in 2004. In comparison, the rates for black Americans has declined. (JAMA)

The data, which encompass almost  250,000 people, come from the National Center for Health Statistics and information it collects from death certificates. They raise more questions on whether the country’s screening standards should be revisited. Current guidelines call for regular screening for colorectal cancer to begin at age 50.

The analysis of mortality rates contained another surprise: They are also rising for white men and women in their 50s despite the actual cancer incidence decreasing and screening recommended for this age group for decades. In contrast, the mortality rates for blacks in their 50s has declined since 1993.


Contact Connie or join us at the Health Care Network Alliance to stop cancer with whole foods, exercise, sleep and supplementation that affects the gene expression to effect health, vitality and youth. motherhealth@gmail.com or text 408-854-1883 to tailor fit supplementation based on your health.

card motherhealth

  • Distributorship ID #: USW9578356
  • Distributorship Address: 1708 Hallmark Lane, San Jose, Ca 95124
    • DELLO BUONO, CONNIE
  • Join our team at Health Care Network Alliance as customer or distributor:
  • Get Health Coach training and cert from Connie and join the training in Utah on Sept 14 and 15 to help doctors use a micro nutrient tester and bring unique wellness solutions for each person.

Signs and symptoms of autoimmune disease

  • Rheumatoid arthritis

    Rheumatoid arthritis affects joint linings, causing painful swelling. Over long periods of time, the inflammation associated with rheumatoid arthritis can cause bone erosion and joint deformity.
  • Lupus

    Symptoms vary but can include fatigue, joint pain, rash, and fever. These can periodically get worse (flare-up) and then improve.
  • Celiac disease

    The classic symptom is diarrhea. Other symptoms include bloating, gas, fatigue, low blood count (anemia), and osteoporosis. Many people have no symptoms.
  • Sjögren’s syndrome

    The main symptoms are dry mouth and dry eyes.
  • Polymyalgia rheumatica

    Symptoms usually develop quickly and include aching of the shoulders, neck, or hips
  • Multiple sclerosis

    Multiple sclerosis causes many different symptoms, including vision loss, pain, fatigue, and impaired coordination. The symptoms, severity, and duration can vary from person to person. Some people may be symptom free most of their lives, while others can have severe chronic symptoms that never go away.
  • Ankylosing spondylitis

    Symptoms typically appear in early adulthood and include reduced flexibility in the spine. This reduced flexibility eventually results in a hunched-forward posture. Pain in the back and joints is also common.
  • Type 1 diabetes

    Symptoms include increased thirst, frequent urination, hunger, fatigue, and blurred vision.
  • Alopecia areata

    The main symptom is hair loss.
  • Vasculitis

    Symptoms include fever, fatigue, weight loss, and muscle and joint pain.
  • Temporal arteritis

    Symptoms include headaches, jaw pain, vision loss, fever, and fatigue. Diagnosis usually requires biopsy of the temporal artery.

Newborn genetic screening in one blood test

American College of Medical Genetics recommendations

Core panel

The following conditions and disorders were recommended as a “core panel” by the 2005 report of the American College of Medical Genetics (ACMG).[1] The incidences reported below are from the full report, though the rates may vary in different populations.[2]

Blood cell disorders

Inborn errors of amino acid metabolism

Inborn errors of organic acid metabolism

Inborn errors of fatty acid metabolism

Miscellaneous multisystem diseases

Newborn screening by other methods than blood testing

Secondary targets

The following disorders are additional conditions that may be detected by screening. Many are listed as “secondary targets” by the 2005 ACMG report.[1] Some states are now screening for more than 50 congenital conditions. Many of these are rare and unfamiliar to pediatricians and other primary health care professionals.[1]

Blood cell disorders

Inborn errors of amino acid metabolism

Inborn errors of organic acid metabolism

Inborn errors of fatty acid metabolism

Miscellaneous multisystem diseases

Bioethics

As additional tests are discussed for addition to the panels, issues arise. Many question if the expanded testing still falls under the requirements necessary to justify the additional tests.[50] Many of the new diseases being tested for are rare and have no known treatment, while some of the diseases need not be treated until later in life.[50] This raises more issues, such as: if there is no available treatment for the disease should we test for it at all? And if we do, what do we tell the families of those with children bearing one of the untreatable diseases?[51] Studies show that the more rare the disease is and the more diseases being tested for, the more likely the tests are to produce false-positives.[52] This is an issue because the newborn period is a crucial time for the parents to bond with the child, and it has been noted that ten percent of parents whose children were diagnosed with a false-positive still worried that their child was fragile and/or sickly even though they were not, potentially preventing the parent-child bond forming as it would have otherwise.[51] As a result, some parents may begin to opt out of having their newborns screened. Many parents are also concerned about what happens with their infant’s blood samples after screening. The samples were originally taken to test for preventable diseases, but with the advance in genomic sequencing technologies many samples are being kept for DNA identification and research,[50][51]increasing the possibility that more children will be opted out of newborn screening from parents who see the kept samples as a form of research done on their child.


Connie’s comments: In the past, it takes 5 years or more to do one test at a time for any metabolic or newborn health screens. Now with the latest medical device and biotech technologies, multiple health screens (genetic) can be done in one blood test.

Genetic tests for 1-5yr olds to help you prepare for any health issues 18yrs later

 

Know your gut microbiome, stop obesity and future infectious disease

stool.JPGmed-gut-2med-gutmed-diet

milk-2

cyto.JPG

candida.JPG

Sequence your microbiome and get a personalized diet plan

Order your gut DNA sequence test from us as we work with the lab by sending us an email at motherhealth@gmail.com to get a free personalized diet plan.

colon-health-3colon-health

 

And work with a genetic counselor.

Your gut microbiome controls production of cytokine.

Gut microbiome is affected by diet and medication.

Sequence your gut bacteria 3 times, $199. Before and after and another 6m later to see the effect of diet, lifestyle and stress/other factors in the bacteria diversity in your gut.

Not all bacteria are hereditable.

gut-swab-2gut-swab


About Cytokine

Cytokines (cyto, from Greek “κύτταρο” kyttaro “cell” + kines, from Greek “κίνηση” kinisi “movement”) are a broad and loose category of small proteins (~5–20 kDa) that are important in cell signaling. Their release has an effect on the behavior of cells around them. It can be said that cytokines are involved in autocrine signalling, paracrine signalling and endocrine signalling as immunomodulating agents. Their definite distinction from hormones is still part of ongoing research. Cytokines include chemokines, interferons, interleukins, lymphokines, and tumour necrosis factorsbut generally not hormones or growth factors (despite some overlap in the terminology). Cytokines are produced by a broad range of cells, including immune cells like macrophages, B lymphocytes, T lymphocytes and mast cells, as well as endothelial cells, fibroblasts, and various stromal cells; a given cytokine may be produced by more than one type of cell.[1][2][3]

They act through receptors, and are especially important in the immune system; cytokines modulate the balance between humoral and cell-basedimmune responses, and they regulate the maturation, growth, and responsiveness of particular cell populations. Some cytokines enhance or inhibit the action of other cytokines in complex ways.[3]

They are different from hormones, which are also important cell signaling molecules, in that hormones circulate in less variable concentrations and hormones tend to be made by specific kinds of cells.

They are important in health and disease, specifically in host responses to infection, immune responses, inflammation, trauma, sepsis, cancer, and reproduction.


About PPI medication

Proton pump inhibitors (PPIs) are a group of drugs whose main action is a pronounced and long-lasting reduction of gastric acid production. Within the class of medications, there is no clear evidence that one agent works better than another.[1][2]

They are the most potent inhibitors of acid secretion available.[3] This group of drugs followed and largely superseded another group of medications with similar effects, but a different mode of action, called H2-receptor antagonists.